In a new study, Honda and colleagues identify a consortium of human gut microbiota that can boost the efficacy of anticancer immune therapy. Click to show full abstract
In a new study, Honda and colleagues identify a consortium of human gut microbiota that can boost the efficacy of anticancer immune therapy.
               
Click one of the above tabs to view related content.